Development rate of chronic kidney disease in hepatitis C virus patients with advanced fibrosis after interferon therapy. | Hepatol Res;41(10): 946-54, 2011 Oct. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Development rate of chronic kidney disease in hepatitis C virus patients with advanced fibrosis after interferon therapy.

Arase, Yasuji; Suzuki, Fumitaka; Kawamura, Yusuke; Suzuki, Yoshiyuki; Kobayashi, Masahiro; Matsumoto, Naoki; Akuta, Norio; Sezaki, Hitomi; Hosaka, Tetsuya; Ogawa, Kyoko; Imai, Norihiro; Seko, Yuya; Saito, Satoshi; Ikeda, Kenji; Kobayashi, Mariko; Kumada, Hiromitsu.

Affiliation

Arase Y; Department of Hepatology and Okinaka Memorial Institute for Medical Research, Toranomon Hospital, Tokyo, Japan.

Hepatol Res ; 41(10): 946-54, 2011 Oct.

Article in En | MEDLINE | ID: mdl-21883737

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Hepatol Res Year: 2011 Document type: Article Affiliation country:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Hepatol Res Year: 2011 Document type: Article Affiliation country: